Janine Divenuto serves as Executive at Atlas Therapeutics Corp, where they oversee executive responsibilities. Since joining the company, Janine Divenuto has executed 8 insider transactions totaling $1.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 14, 2011 involved purchasing 1,000 shares valued at $240.
Janine Divenuto currently holds 7,757,000 shares of Atlas Therapeutics Corp (ATTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Janine Divenuto has been a net buyer of ATTH stock. They have purchased $1.7K and sold $0 worth of shares.
Janine Divenuto's most recent insider trade was on Oct 14, 2011, when they purchased 1,000 shares at $0.24 per share.
Get notified when new Form 4 filings are submitted
| $0.20 |
| Discretionary |
| Oct 10, 2011 | ATTH | $200 | Purchase | 1,000 | $0.20 | Discretionary |
| Oct 6, 2011 | ATTH | $480 | Purchase | 2,000 | $0.24 | Discretionary |
| Oct 3, 2011 | ATTH | $210 | Purchase | 700 | $0.30 | Discretionary |
| Oct 3, 2011 | ATTH | $128 | Purchase | 400 | $0.32 | Discretionary |
| Oct 3, 2011 | ATTH | $145 | Purchase | 500 | $0.29 | Discretionary |
| Sep 30, 2011 | ATTH | $128 | Purchase | 400 | $0.32 | Discretionary |